Novonesis
411
DKK
-0.46 %
Less than 1K followers
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
-0.46%
+2.8%
+0.46%
+0.81%
-7.1%
+5.49%
-14.94%
+29.65%
+1,010.81%
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Read moreMarket cap
192.47B DKK
Turnover
131.06M DKK
Revenue
28.59B
EBIT %
13.07 %
P/E
82.25
Dividend yield-%
1.02 %
Financial calendar
13/8
2025
Interim report Q2'25
All
Press releases
ShowingAll content types
Andrew Taylor joins Novonesis’ Executive Leadership Team
Transactions under Novonesis’ share buyback program
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools